USP15 and acute myeloid leukemia: To test whether USP15-Inh can also reduce cellular ROS in leukemic cells, we treated a panel of AML cell lines with USP15-Inh for 24 h and evaluated cellular ROS using 2′,7′-dichlorofluorescin diacetate (DCFDA).